Latest News in the pharma Industry
Market News
UPDATED: COVID-19 Pharma Development Tracker
1 Mar 2021
The latest coronavirus updates and developments impacting the global pharmaceutical supply chain
Read more
Catalent takes double action to boost cell and gene therapy services
23 Feb 2021
The company acquires a pDNA CDMO and launches pDNA development and manufacturing services at its Rockville, Maryland facility
Read more
BMS expands global footprint with new cell therapy manufacturing facility
23 Feb 2021
The new site will be equipped to enable quick ramp-up of capacity for clinical and commercial cell therapy products
Read more
Catalent secures softgels commercial supply agreement with Aurinia
22 Feb 2021
The CDMO will manufacture recently FDA-approved Lupkynis as a softgel dosage form at its St Petersburg, Florida, facility
Read more
MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal
22 Feb 2021
The manufacturing agreement includes process development for scale-up and technology transfer with the goal of supplying Phase II and III clinical studies
Read more
Wavelength takes majority stake in Vanamali to strengthen drug substance manufacturing
18 Feb 2021
API manufacturer says acquisition is next step of investment strategy to closely align API supply to customer needs in an unpredictable world
Read more
Cascade Chemistry starts $14 million API manufacturing expansion
18 Feb 2021
CDMO says increased customer demand for clinical API supply has outstripped its cGMP manufacturing capacity
Read more
Regis completes expansion of US-based API development facility
17 Feb 2021
The CDMO doubles its capacity to take on new development projects
Read more
Lonza boosts solid form services for small molecule APIs
16 Feb 2021
The expanded and refined first-in-human services have been designed to meet the early-stage molecule development of small biopharma players
Read more
Phlow secures $20 million to advance manufacturing initiatives in the US
16 Feb 2021
The company seeks to actively accelerate US manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response
Read more
Dermapharm expands COVID-19 vaccine production capacity at ex-Merck site
15 Feb 2021
The company's additional production capacities are scheduled to go into operation in May 2021
Read more
AstraZeneca partners with IDT Biologika to build COVID-19 vaccine facility in Germany
11 Feb 2021
Firms plan to invest in capacity expansion at the CDMO’s manufacturing site in Dessau to boost European domestic vaccine supply
Read more